Statins for treatment of dyslipidemia in chronic kidney disease.

  title={Statins for treatment of dyslipidemia in chronic kidney disease.},
  author={Sabin Shurraw and Marcello Tonelli},
  journal={Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis},
  volume={26 5},
Dyslipidemia is a potent cardiovascular (CV) risk factor in the general population. Elevated low-density lipoprotein cholesterol (LDL-C) and/or low high-density lipoprotein (HDL-C) are well-established CV risk factors, but more precise determinants of risk include increased apoprotein B (ApoB), lipoprotein(a) [Lp(a)], intermediate and very low-density lipoprotein (IDL-C, VLDL-C; "remnant particles"), and small dense LDL particles. Lipoprotein metabolism is altered in association with declining… CONTINUE READING
21 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 21 extracted citations

Similar Papers

Loading similar papers…